Beyond Li Fraumeni Syndrome: Clinical Characteristics of Families With p53 Germline Mutations
Top Cited Papers
- 10 March 2009
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 27 (8), 1250-1256
- https://doi.org/10.1200/jco.2008.16.6959
Abstract
A clinical testing cohort was used to gain a broader understanding of the spectrum of tumors associated with germline p53 mutations to aid clinicians in identifying high-risk families. Full sequencing of the coding exons (2 to 11) and associated splice junctions of the p53 gene was performed on 525 consecutive patients whose blood samples were submitted for diagnostic testing. Clinical features of p53 germline carriers in this cohort were characterized, clinical referral schemes based on reported p53-associated family phenotypes were evaluated, and practical mutation prevalence tables were generated. Mutations were identified in 91 (17%) of 525 patients submitted for testing. All families with a p53 mutation had at least one family member with a sarcoma, breast, brain, or adrenocortical carcinoma (ACC). Every individual with a choroid plexus tumor (eight of eight) and 14 of 21 individuals with a childhood ACC had a mutation regardless of family history. Based on reported personal and family history, 95% of patients (71 of 75) with a mutation met either classic Li Fraumeni syndrome (LFS) or Chompret criteria. A simplified prevalence table provides a concise summary of individual and family characteristics associated with p53 mutations. This is, to our knowledge, the largest single report of diagnostic testing for germline p53 mutations, yielding practical mutation prevalence tables and suggesting clinical utility of classic LFS and Chompret criteria for identifying a subset of cancer-prone families with p53 germline mutations, with important implications for diagnosis and management.Keywords
This publication has 22 references indexed in Scilit:
- Highly penetrant hereditary cancer syndromesOncogene, 2004
- Germline p53 Mutations in a Cohort with Childhood Sarcoma: Sex Differences in Cancer RiskAmerican Journal of Human Genetics, 2003
- A role for p53 in the frequency and mechanism of mutationMutation Research - Reviews in Mutation Research, 2002
- Sensitivity and predictive value of criteria for p53germline mutation screeningJournal of Medical Genetics, 2001
- TrueBritish Journal of Cancer, 2000
- Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni SyndromeScience, 1999
- Two Li-Fraumeni syndrome families with novel germline p53 mutations: loss of the wild-type p53 allele in only 50% of tumours.British Journal of Cancer, 1998
- Choroid plexus tumors in the breast cancer–sarcoma syndromeCancer, 1990
- Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other NeoplasmsScience, 1990
- Soft-Tissue Sarcomas, Breast Cancer, and Other NeoplasmsAnnals of Internal Medicine, 1969